Shares Of Epizyme Of Cambridge Skyrocket 80%, After Pair Of Positive DevelopmentsEpizyme stock soared on Tuesday, after the company announced two important payments from its partners in the development of new types of cancer drugs.

More From CBS Boston

Opioid Crisis
Download Our App
Download Weather App

Watch & Listen LIVE